QUOTIENT SCIENCES
Live / Registered — Registered (as of 23 Jun 2026)
What this means for you
Registered since 23 Jun 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Jun 2032: the §71 affidavit of use).
Record
- Serial number
- 79417429
- Registration number
- 8309252
- Mark type
- Word mark
- Filed
- 17 Sept 2024
- Published for opposition
- 05 May 2026
- Registered
- 23 Jun 2026
- Next maintenance filing
- §71 affidavit of use, due by 23 Jun 2032 (grace period to 23 Dec 2032)
- Attorney of record
- Jonathan Soifer
Goods and services
- Class 039 — Transportation and storage services: Contract packaging services in the nature of packaging and labelling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; contract packaging and labelling for other in the nature of merchandise packaging and labelling for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; contract packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials for others
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; providing information about the results of clinical trials for pharmaceutical and biopharmaceutical products, namely providing technical information in the field of custom manufacturing of pharmaceutical and biopharmaceutical products
- Class 042 — Scientific and technological services: Clinical research in the field of pharmacology and medical research; medical and scientific research, namely, conducting clinical trials for others; medical research, namely, conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science namely, scientific research; Scientific research in the nature of basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; Evaluation and analysis of the efficacy and dosages of pharmaceutical and biopharmaceutical products of others and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials in the nature of information regarding testing of pharmaceutical and biopharmaceutical products; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely conducting early evaluations in the field of new pharmaceutical and testing, inspection and research of pharmaceuticals; scientific research in the nature of conducting clinical trials for others for the purpose of optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others; Research relating to medicine, namely, medical research in the field of pharmacology; Medical research in the nature of basic and clinical research in the field of pharmacology; consultancy relating to testing, inspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals
Owner
Prosecution history
- 23 Sept 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 06 Aug 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 20 Jul 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 19 Jul 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 23 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 May 2026 — PUBLISHED FOR OPPOSITION
- 29 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Apr 2026 — EXAMINER'S AMENDMENT ENTERED
- 07 Apr 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 07 Apr 2026 — EXAMINERS AMENDMENT E-MAILED
- 07 Apr 2026 — EXAMINERS AMENDMENT -WRITTEN
- 26 Feb 2026 — ASSIGNED TO EXAMINER